Further studies on long-term contraception by subcutaneous silastic R capsules containing megestrol acetate
Coutinho, E.M.; Mattos, C.E.; Sant'Anna, A.R.; Filho, J.A.; Silva, M.C.; Tatum, H.J.
Contraception 5(5): 389-393
1972
ISSN/ISBN: 0010-7824 PMID: 4650656 DOI: 10.1016/0010-7824(72)90030-3Document Number: 520277
Document emailed within 0-6 h
Related Documents
Narula, R.K.; Chandra, V.L.; Dugwekar, Y.G.; Rahman, S.A.; Laumas, K.R. 1975: Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women Indian Journal of Medical Research 63(11): 1620-1628Narula, R.K.; Chandra, V.L.; Dugwekar, Y.G.; Rahman, S.A.; Laumas, K.R. 1975: Long-term contraception by steroid releasing implants. III. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women Indian Journal of Medical Research 63(11): 1620-1628
Bhatnagar, S.; Srivastava, U.K.; Takkar, D.; Chandra, V.L.; Hingorani, V.; Laumas, K.R. 1975: Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women Contraception 11(5): 505-521
Wiese, J.; Marker, I.L.; Holma, P.; Vartiainen, E.; Osler, M.; Pyörälä, T.; Johansson, E.; Luukkainen, T. 1976: Long-term contraception with norethindrone subcutaneous capsules Annals of Clinical Research 8(2): 93-97
Takkar, D.; Anandalaxmi, P.N.; Chandra, V.L.; Bhatnagar, S.; Yadav, H.S.; Laumas, K.R.; Hingorani, V.; Krishna, U.; Mandleker, A.; Purandare, V.N.; Goel, V.; Adatia, A.; Virker, K.D. 1978: Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation Contraception 17(4): 341-354
Peng, Q. 1985: Sister-chromatid exchange studies in women with long-term use of the oral contraceptive pills megestrol acetate compositas Zhonghua Fu Chan Ke Za Zhi 20(5): 309
Benagiano, G.; Ermini, M.; Carenza, L.; Rolfini, G. 1973: Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 1. Diffusion of megestrol acetate in humans Acta Endocrinologica 73(2): 335-346
Kanitkar, S.D.; Ranade, V.D. 1970: Evaluation of sequential method of contraception with megestrol acetate and ethinyl oestradiol Journal of Obstetrics and Gynaecology of India 20(1): 102-105
Osler, M. 1979: Subcutaneous steroid hormone capsules. the future contraception? Ugeskrift for Laeger 141(45): 3097-3099
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Taneepanichskul, S.; Patrachai, S. 1998: Effects of long-term treatment with depot medroxy progesterone acetate for contraception on estrogenic activity Journal of the Medical Association of Thailand 81(12): 944-946
Hingorani, V.; Jalnawala, S.F.; Kochhar, M.; Rai Chaudhury, G.; Sengupta, P.C.; Datey, S.; Mehta, S.; Roy, M.; Saxena, N.C.; Saxena, B.N. 1986: Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction Contraception 33(3): 233-244
Hingorani, V.; Jalnawala, S.F.; Kochhar, M.; Rai Chaudhury, G.; Sengupta, P.C.; Datey, S.; Mehta, S.; Roy, M.; Saxena, N.C.; Saxena, B.N. 1986: Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction Contraception 33(3): 233-244
Mantovani, G.; Macciò, A.; Lai, P.; Massa, E.; Ghiani, M.; Santona, M.C. 1998: Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate Seminars in Oncology 25(2 Suppl 6: 45-52
Prabhakaran, S.; Sweet, A. 2012: Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability Contraception 85(5): 453-457
Krashin, J.W.; Stuart, G.S.; Garrett, J.; Spector, H.; Bryant, A.G.; Charm, S.; Morse, J.E. 2017: Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion Obstetrics and gynecology 130(1): 109-117
Kurunmäki, H.; Toivonen, J.; Lähteenmäki, P.; Luukkainen, T. 1985: Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules Contraception 31(3): 305-318
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72
Stout, A.; Wood, S.; Barigye, G.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries Global Health Science and Practice 6(1): 55-72